Semaglutide Reduces Alcohol Drinking in Mice: Potential Addiction Treatment
The FDA-approved diabetes drug semaglutide reduces alcohol drinking in mice and rats, suggesting it could be repurposed as an effective medication for alcohol use disorder (AUD). Key findings include: Semaglutide dose-dependently decreased binge-like drinking in both male and female mice. In rats, semaglutide reduced binge-like and dependence-induced alcohol drinking. Semaglutide also decreased consumption of caloric …
